Myriad pressures have the industry looking toward global R&D outsourcing as a life raft in a sea of change.
A U.K. report by Deloitte and Thomson Reuters surveyed a dozen pharmaceutical companies that spent the most on developing new drugs and discovered that they spent 25% more to bring a product to market in 2011 than in 2010, while the average commercial value of products remained the same as in 2010. The average cost of successfully bringing a product to market increased from $830 million in 2010 to $1.04 billion in 2011. The overall rate of return on R&D dropped from…
Global Clinical Trials By Country
Tips for Successful R&D Outsourcing
PharmaVOICE: Going Global in 2012
Glen de Vries. President, Medidata Solutions Worldwide, a global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. For more information, visit mdsol.com.
Anup Kharode. Director, Global Pharma & Life Sciences, PwC, which provides assurance, tax, and advisory services to proprietary, generic, and specialty drug manufacturers, medical device and instrumentation suppliers, biotechnology companies, wholesalers, pharmacy benefit managers, CROs, and industry associations. For more information, visit pwc.com.
Nagaraja Srivatsan. Senior VP and Head of the Life Sciences Practices, North America, Cognizant, a global provider of information technology, consulting, and business process outsourcing services. For more information, visit cognizant.com.